Tagged with IP

Canada Referring to the Canadian affiliate of Zimmer Biomet as a “trailblazer”, Dave O’Neil looks back on a successful 2017 for the musculoskeletal healthcare company in Canada. He describes how Zimmer Biomet positions itself as a true partner in driving efficiency in the Canadian healthcare system. 2017 was an eventful year…

Portugal Oscar Gaspar, VP of the Confederation of Portuguese Industry (CIP), president of the Portuguese Association of Private Hospitalization and former secretary of state for health (2009-2011), provides an informative insight into the state of Portugal’s healthcare system. Through compelling suggestions and observations on the current system, Gaspar sheds light on…

Portugal Salvador Lopez saw an opportunity in the summer of 2015 to create the first Portuguese affiliate for Mundipharma. Three years on, he reveals how their business model, company culture and leadership has succeeded in disrupting the respiratory market with their blockbuster drug Flutiform, built the fastest growing subsidiary in Portugal…

Canada Having just announced the first collaboration between a medical cannabis company and a major pharmaceutical player, Tilray expects to launch its first co-branded product with Sandoz Canada by the end of the year. Tilray’s founder and CEO Brendan Kennedy highlights the company’s main differentiation factors, including but not limited to…

Poland Dariusz Adamusiński, general manager of A&D Pharma’s Polish operations has a busy year ahead. A new warehouse in Poland, partnerships across the pharmaceutical spectrum coupled with new regulations are all positive signs for the company.  Could you introduce A&D Pharma’s scope of operations in Poland? “Many other pharma companies are…

Ecuador Francisco Cordero, general manager of Rocnarf, a proudly Ecuadorian family company with over 40 years of experience in the market discusses the company’s recent rebounding from experiencing severe price controls on its products. Looking forward, Cordero intends to develop international activities in collaboration with European, Middle Eastern and Central Asian…

India The top 15 pharma companies in India for 2017 ranked by market share and growth rate. Homegrown champions Sun Pharma, Cipla and Zydus Cadila lead the way with 5.5, 4.6 and 3.9% market shares respectively.

Canada John Simmons, VP Sales & Marketing (Health Systems) at Philips Canada talks about the company’s commitment to delivering integrated health technology solutions that provide continuous care across the health continuum. Can you provide an overview of Philips operations in Canada? “Philips Canada is very active in our customer-oriented focus; we…

Lithuania Aki Kasvi and Mindaugas Plieskis of Janssen Baltics discuss their strategic priorities, acting as a strategic partner within the region, and ensuring that patients can access their innovative latest-generation therapies Mr Kasvi, you were nominated to head up Janssen’s Lithuanian office back in November 2017. What was the strategic mission…

Poland Maciej Wieczorek, president of Celon Pharma, discusses the award-winning success of the 2016 IPO on the Warsaw stock exchange and the opportunities this has opened up, as well as investment strategy to assure the company’s impressive growth. Furthermore, he surveys the Polish R&D landscape and discusses the importance of a…

India Umang Vohra, managing director and global CEO of Indian pharma giant Cipla, discusses the company’s ambition to grow in both the domestic and emerging markets as well as the opportunities that Cipla sees as a specialty pharmaceutical company in the US.   The opportunity to service such a vast patient…

Canada Tarik Henein, president of Generic Medical Partners, explains the company’s commitment to improving the lives of Canadians by connecting global generic development and manufacturing companies with the Canadian market. He further comments on the key points for navigating the complex Canadian pharmaceutical market and how GMP combines a unique flexibility…